Two Sigma Advisers »

An2 Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $290k 135k 2.15

More positions owned by Two Sigma Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Uber Technologies (UBER)
Mastercard Incorporated Cl A (MA)
Pfizer (PFE)
Crowdstrike Hldgs Cl A (CRWD)
Micron Technology (MU)
Abbott Laboratories (ABT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Two Sigma Advisers

Top funds holding An2 Therapeutics

BML Capital Management
RA Capital Management
TCG Crossover Management
Henderson Group
Vanguard Group
Acuitas Investments
Renaissance Technologies
BlackRock
BlackRock
Goldman Sachs Group
Geode Capital Management
Ghost Tree Capital
Two Sigma Advisers
Two Sigma Investments
Bridgeway Capital Management

View all funds holding An2 Therapeutics